Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors

被引：72

作者：

Bamborough, Paul ^{[1
]}

Chung, Chun-wa ^{[1
]}

Furze, Rebecca C. ^{[2
]}

Grandi, Paola ^{[4
]}

Michon, Anne-Marie ^{[4
]}

Sheppard, Robert J. ^{[2
]}

Barnett, Heather ^{[3
]}

Diallo, Hawa ^{[2
]}

Dixon, David P. ^{[1
]}

Douault, Clement ^{[2
]}

Jones, Emma J. ^{[1
]}

Karamshi, Bhumika ^{[1
]}

Mitchell, Darren J. ^{[2
]}

Prinjha, Rab K. ^{[2
]}

Rau, Christina ^{[4
]}

Watson, Robert J. ^{[2
]}

Wemer, Thilo ^{[4
]}

Demont, Emmanuel H. ^{[2
]}

机构：

[1] GlaxoSmithKline Med Res Ctr, Mol Discovery Res, Stevenage SG1 2NY, Herts, England

[2] GlaxoSmithKline Med Res Ctr, Epinova Discovery Performance Unit, Stevenage SG1 2NY, Herts, England

[3] GlaxoSmithKline Med Res Ctr, Flexible Discovery Unit, Stevenage SG1 2NY, Herts, England

[4] GlaxoSmithKline, Mol Discovery Res, Cellzome GmbH, D-69117 Heidelberg, Germany

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2015年 / 58卷 / 15期

关键词：

DISCOVERY;

D O I：

10.1021/acs.jmedchem.5b00773

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

ATAD2 is a bromodomain-containing protein whose overexpression is linked to poor outcomes in a number of different cancer types. To date, no potent and selective inhibitors of the bromodomain have been reported. This article describes the structure-based optimization of a series of naphth-yridones from micromolar leads with no selectivity over the BET bromodomains to inhibitors with sub-100 nM ATAD2 potency and 100-fold BET selectivity.

引用

页码：6151 / 6178

页数：28

共 50 条

[31] Structure-based optimization of PKCθ inhibitors
Mosyak, L.
Xu, Z.
Joseph-McCarthy, D.
Brooijmans, N.
Somers, W.
Chaudhary, D.
BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 1027 - 1031
[32] Structure-based optimization of MurF inhibitors
Stamper, GF
Longenecker, KL
Fry, EH
Jakob, CG
Florjancic, AS
Gu, YG
Anderson, DD
Cooper, CS
Zhang, T
Clark, RF
Cia, Y
Black-Schaefer, CL
McCall, JO
Lerner, CG
Hajduk, PJ
Beutel, BA
Stoll, VS
CHEMICAL BIOLOGY & DRUG DESIGN, 2006, 67 (01) : 58 - 65
[33] Structure-based discovery of selective BRPF1 bromodomain inhibitors
Zhu, Jian
Zhou, Chunxian
Caflisch, Amedeo
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 155 : 337 - 352
[34] Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitors
Li, Hui
Tatlock, John
Linton, Angelica
Gonzalez, Javier
Borchardt, Allen
Dragovich, Peter
Jewell, Tanya
Prins, Tom
Zhou, Ru
Blazel, Julie
Parge, Hans
Love, Robert
Hickey, Michael
Doan, Chau
Shi, Stephanie
Duggal, Rohit
Lewis, Cristina
Fuhrman, Shella
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (18) : 4834 - 4838
[35] Discovery of a New Class of Potent MMP Inhibitors by Structure-Based Optimization of the Arylsulfonamide Scaffold
Mori, Mattia
Massaro, Assunta
Calderone, Vito
Fragai, Marco
Luchinat, Claudio
Mordini, Alessandro
ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (06): : 565 - 569
[36] Optimization of Potent and Specific Trypanothione Reductase Inhibitors: A Structure-Based Drug Discovery Approach
Battista, Theo
Federico, Stefano
Brogi, Simone
Pozzetti, Luca
Khan, Tuhina
Butini, Stefania
Ramunno, Anna
Fiorentino, Eleonora
Orsini, Stefania
Di Muccio, Trentina
Fiorillo, Annarita
Exertier, Cecile
Di Risola, Daniel
Ilari, Andrea
Campiani, Giuseppe
Colotti, Gianni
Gemma, Sandra
ACS INFECTIOUS DISEASES, 2022, 8 (08): : 1687 - 1699
[37] Structure-Based Screening and Optimization of PafA Inhibitors with Potent Anti-Tuberculosis Activity
Jiang, Hewei
Xie, Jin
Wang, Lei
Chen, Hong
Zheng, Yunxiao
Wang, Xuening
Guo, Shujuan
Wang, Tao
Bi, Jing
Zhang, Xuelian
Pei, Jianfeng
Tao, Shengce
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (23)
[38] Structure-based optimization of hydroxylactam as potent, cell-active inhibitors of lactate dehydrogenase
Wei, BinQing
Robarge, Kirk
Labadie, Sharada S.
Chen, Jinhua
Corson, Laura B.
DiPasquale, Antonio
Dragovich, Peter S.
Eigenbrot, Charles
Evangelista, Marie
Fauber, Benjamin P.
Hitz, Anna
Hong, Rebecca
Lai, Kwong Wah
Liu, Wenfeng
Ma, Shuguang
Malek, Shiva
O'Brien, Thomas
Pang, Jodie
Peterson, David
Salphati, Laurent
Sampath, Deepak
Sideris, Steven
Ultsch, Mark
Xu, Zijin
Yen, Ivana
Yu, Dong
Yue, Qin
Zhou, Aihe
Purkey, Hans E.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 59
[39] Molecular docking and QSAR analysis of naphthyridone derivatives as ATAD2 bromodomain inhibitors: application of CoMFA, LS-SVM, and RBF neural network
Bakhtyar Sepehri
Zolaikha Rasouli
Zeinabe Hassanzadeh
Raouf Ghavami
Medicinal Chemistry Research, 2016, 25 : 2895 - 2905
[40] Molecular docking and QSAR analysis of naphthyridone derivatives as ATAD2 bromodomain inhibitors: application of CoMFA, LS-SVM, and RBF neural network
Sepehri, Bakhtyar
Rasouli, Zolaikha
Hassanzadeh, Zeinabe
Ghavami, Raouf
MEDICINAL CHEMISTRY RESEARCH, 2016, 25 (12) : 2895 - 2905

← 1 2 3 4 5 →